These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 25717246)
1. Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B. Shimizu M; Furusyo N; Ikezaki H; Ogawa E; Hayashi T; Ihara T; Harada Y; Toyoda K; Murata M; Hayashi J World J Gastroenterol; 2015 Feb; 21(7):2116-23. PubMed ID: 25717246 [TBL] [Abstract][Full Text] [Related]
2. Osteomalacia induced by long-term low-dose adefovir dipivoxil: Clinical characteristics and genetic predictors. Wei Z; He JW; Fu WZ; Zhang ZL Bone; 2016 Dec; 93():97-103. PubMed ID: 27664568 [TBL] [Abstract][Full Text] [Related]
3. Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B. Jia HY; Ding F; Chen JY; Lian JS; Zhang YM; Zeng LY; Xiang DR; Yu L; Hu JH; Yu GD; Cai H; Lu YF; Zheng L; Li LJ; Yang YD World J Gastroenterol; 2015 Mar; 21(12):3657-62. PubMed ID: 25834334 [TBL] [Abstract][Full Text] [Related]
4. Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series. Chen N; Zhang JB; Zhang Q; Zhao YP; Li LY; Liu LW; Yu F; Yu X; Peng T; Tang KX BMC Pharmacol Toxicol; 2018 May; 19(1):23. PubMed ID: 29769119 [TBL] [Abstract][Full Text] [Related]
5. Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients. Kim YJ; Cho HC; Sinn DH; Gwak GY; Choi MS; Koh KC; Paik SW; Yoo BC; Lee JH J Gastroenterol Hepatol; 2012 Feb; 27(2):306-12. PubMed ID: 21777281 [TBL] [Abstract][Full Text] [Related]
6. Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible? Qian YY; Dai ZJ; Ruan LY; Pan YJ; Jin J; Shi MT; Zhu YX; Wu CM Drug Des Devel Ther; 2019; 13():1127-1133. PubMed ID: 31118563 [TBL] [Abstract][Full Text] [Related]
7. The clinical and pathological features of adefovir dipivoxil-related renal impairment . Lv Y; Li X; Liang S; Liang D; Xu F; Zhu X; Zeng C Clin Nephrol; 2019 Mar; 91(3):180-186. PubMed ID: 30614440 [TBL] [Abstract][Full Text] [Related]
8. Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by low-dose adefovir dipivoxil: a case report and literature review suggesting ethnic predisposition. Wu C; Zhang H; Qian Y; Wang L; Gu X; Dai Z J Clin Pharm Ther; 2013 Aug; 38(4):321-6. PubMed ID: 23590583 [TBL] [Abstract][Full Text] [Related]
9. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study. Pellicelli AM; Barbaro G; Francavilla R; Romano M; Barbarini G; Mazzoni E; Mecenate F; Paffetti A; Barlattani A; Struglia C; Villani R; Nauri L; Nosotti L; Armignacco O; Ferri F; Camporiondo MP; Soccorsi F; Clin Ther; 2008 Feb; 30(2):317-23. PubMed ID: 18343270 [TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms in ABCC2 associate with tenofovir-induced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study. Nishijima T; Komatsu H; Higasa K; Takano M; Tsuchiya K; Hayashida T; Oka S; Gatanaga H Clin Infect Dis; 2012 Dec; 55(11):1558-67. PubMed ID: 22955427 [TBL] [Abstract][Full Text] [Related]
11. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. Ha NB; Ha NB; Garcia RT; Trinh HN; Vu AA; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH Hepatology; 2009 Sep; 50(3):727-34. PubMed ID: 19517525 [TBL] [Abstract][Full Text] [Related]
12. Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B. Tanaka M; Suzuki F; Seko Y; Hara T; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H J Gastroenterol; 2014 Mar; 49(3):470-80. PubMed ID: 23525978 [TBL] [Abstract][Full Text] [Related]
13. Acquired Fanconi syndrome associated with prolonged adefovir dipivoxil therapy in a chronic hepatitis B patient. Law ST; Li KK; Ho YY Am J Ther; 2013; 20(6):e713-6. PubMed ID: 21519215 [TBL] [Abstract][Full Text] [Related]
14. Osteomalacia and Fanconi's syndrome caused by long-term low-dose adefovir dipivoxil. Wang BF; Wang Y; Wang BY; Sun FR; Zhang D; Chen YS J Clin Pharm Ther; 2015 Jun; 40(3):345-8. PubMed ID: 25721615 [TBL] [Abstract][Full Text] [Related]
15. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy. Lee M; Oh S; Lee HJ; Yeum TS; Lee JH; Yu SJ; Kim HY; Yoon JH; Lee HS; Kim YJ J Viral Hepat; 2014 Dec; 21(12):873-81. PubMed ID: 24351112 [TBL] [Abstract][Full Text] [Related]
16. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients. Yang DH; Xie YJ; Zhao NF; Pan HY; Li MW; Huang HJ World J Gastroenterol; 2015 Mar; 21(9):2746-53. PubMed ID: 25759545 [TBL] [Abstract][Full Text] [Related]
17. Pathologic Femoral Neck Fracture Due to Fanconi Syndrome Induced by Adefovir Dipivoxil Therapy for Hepatitis B. Lee YS; Kim BK; Lee HJ; Dan J Clin Orthop Surg; 2016 Jun; 8(2):232-6. PubMed ID: 27247753 [TBL] [Abstract][Full Text] [Related]
18. [A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period]. Yang Q; Gong ZJ; Hu DF Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):515-9. PubMed ID: 19912686 [TBL] [Abstract][Full Text] [Related]
19. [Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient with chronic hepatitis B]. Li L; Dong GF; Zhang X; Xie YS Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1956. PubMed ID: 22126791 [TBL] [Abstract][Full Text] [Related]
20. Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: a 4-year study. Vassiliadis TG; Giouleme O; Koumerkeridis G; Koumaras H; Tziomalos K; Patsiaoura K; Grammatikos N; Mpoumponaris A; Gkisakis D; Theodoropoulos K; Panderi A; Katsinelos P; Eugenidis N J Gastroenterol Hepatol; 2010 Jan; 25(1):54-60. PubMed ID: 19780875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]